Celltrion Celebrates Brazilian Tender Win For Infliximab
Remsima Win Follows Truxima (Rituximab) And Herzuma (Trastuzumab) Biosimilars
• By David Wallace
Remsima has become the third Celltrion biosimilar to win a Brazilian tender • Source: Wavebreak Media ltd / Alamy Stock Photo 
